These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9579543)

  • 61. Identification of a Distinct miRNA Regulatory Network in the Tumor Microenvironment of Transformed Mycosis Fungoides.
    Di Raimondo C; Han Z; Su C; Wu X; Qin H; Sanchez JF; Yuan YC; Martinez X; Abdulla F; Zain J; Chen CW; Rosen ST; Querfeld C
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34831008
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mutation of the tumor suppressor gene TP53 is not detected in psoriatic skin.
    Molès JP; Theillet C; Basset-Sèguin N; Guilhou JJ
    J Invest Dermatol; 1993 Jul; 101(1):100-2. PubMed ID: 8331291
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma.
    Hatzl S; Posch F; Schulz E; Gornicec M; Deutsch A; Beham-Schmid C; Pichler M; Greinix H; Sill H; Zebisch A; Neumeister P; Prochazka KT
    Pathol Oncol Res; 2020 Oct; 26(4):2831-2833. PubMed ID: 32602002
    [No Abstract]   [Full Text] [Related]  

  • 64. UVA1 irradiation induces deoxyribonuclease dependent apoptosis in cutaneous T-cell lymphoma in vivo.
    von Kobyletzki G; Heine O; Stephan H; Pieck C; Stücker M; Hoffmann K; Altmeyer P; Mannherz HG
    Photodermatol Photoimmunol Photomed; 2000 Dec; 16(6):271-7. PubMed ID: 11132131
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cytokines and cutaneous T-cell lymphomas.
    Asadullah K; Döcke WD; Volk HD; Sterry W
    Exp Dermatol; 1998 Dec; 7(6):314-20. PubMed ID: 9858133
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cutaneous T-cell lymphoma with Sézary syndrome in a dog.
    Foster AP; Evans E; Kerlin RL; Vail DM
    Vet Clin Pathol; 1997; 26(4):188-192. PubMed ID: 12658584
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cutaneous T-cell lymphoma following dupilumab use: a systematic review.
    Park A; Wong L; Lang A; Kraus C; Anderson N; Elsensohn A
    Int J Dermatol; 2023 Jul; 62(7):862-876. PubMed ID: 36073768
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased p53 staining in normal skin of posttransplant, immunocompromised patients and implications for carcinogenesis.
    Hudson AR; Antley CM; Kohler S; Smoller BR
    Am J Dermatopathol; 1999 Oct; 21(5):442-5. PubMed ID: 10535572
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma.
    Song X; Chang S; Seminario-Vidal L; de Mingo Pulido A; Tordesillas L; Song X; Reed RA; Harkins A; Whiddon S; Nguyen JV; Segura CM; Zhang C; Yoder S; Sayegh Z; Zhao Y; Messina JL; Harro CM; Zhang X; Conejo-Garcia JR; Berglund A; Sokol L; Zhang J; Rodriguez PC; Mulé JJ; Futreal AP; Tsai KY; Chen PL
    Cancer Discov; 2022 May; 12(5):1294-1313. PubMed ID: 35247891
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Primary cutaneous diffuse large B-cell lymphoma presenting as a solitary subcutaneous nodule with TP53 and FBXW7 mutations.
    Yoshimoto N; Yanagi T; Matsumura W; Ujiie I; Izumi K; Ando S; Nishie W; Fujii K; Nishihara H; Shimizu H
    Int J Dermatol; 2017 Dec; 56(12):1459-1461. PubMed ID: 28960258
    [No Abstract]   [Full Text] [Related]  

  • 71. Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma.
    Dulmage BO; Akilov O; Vu JR; Falo LD; Geskin LJ
    Oncotarget; 2019 May; 10(33):3104-3113. PubMed ID: 31139323
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tumor suppression: putting p53 in context.
    Mills KD
    Cell Cycle; 2013 Nov; 12(22):3461-2. PubMed ID: 24131920
    [No Abstract]   [Full Text] [Related]  

  • 73. p53 protein expression in cutaneous T cell lymphoma.
    de Misa RF; Azaña JM; Harto A; Bellas C
    J Dermatol Sci; 1993 Jun; 5(3):212-3. PubMed ID: 8305055
    [No Abstract]   [Full Text] [Related]  

  • 74. p53 immunostaining in dermatopathology.
    McGregor JM; Levison DA; MacDonald DM
    Arch Dermatol; 1994 Apr; 130(4):518-9. PubMed ID: 7513147
    [No Abstract]   [Full Text] [Related]  

  • 75. Protein 53 expression in a mixed Labrador subcutaneous lymphoma.
    Rezaie A; Tavassoli A
    Vet Res Forum; 2012; 3(2):147-9. PubMed ID: 25653762
    [TBL] [Abstract][Full Text] [Related]  

  • 76. XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways.
    Chakravarti N; Boles A; Burzinski R; Sindaco P; Isabelle C; McConnell K; Mishra A; Porcu P
    Sci Rep; 2024 Apr; 14(1):9305. PubMed ID: 38653804
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeted Deep Sequencing of Mycosis Fungoides Reveals Intracellular Signaling Pathways Associated with Aggressiveness and Large Cell Transformation.
    Wobser M; Roth S; Appenzeller S; Houben R; Schrama D; Goebeler M; Geissinger E; Rosenwald A; Maurus K
    Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771672
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Insuline-Like Growth Factor-2 (IGF2) and Hepatocyte Growth Factor (HGF) Promote Lymphomagenesis in p53-null Mice in Tissue-specific and Estrogen-signaling Dependent Manners.
    Huang HS; Chu SC; Chen PC; Lee MH; Huang CY; Chou HM; Chu TY
    J Cancer; 2021; 12(20):6021-6030. PubMed ID: 34539876
    [No Abstract]   [Full Text] [Related]  

  • 79.
    Wooler G; Melchior L; Ralfkiaer E; Rahbek Gjerdrum LM; Gniadecki R
    Front Med (Lausanne); 2016; 3():51. PubMed ID: 27891503
    [No Abstract]   [Full Text] [Related]  

  • 80. Increased Twist expression in advanced stage of mycosis fungoides and Sézary syndrome.
    Goswami M; Duvic M; Dougherty A; Ni X
    J Cutan Pathol; 2012 May; 39(5):500-7. PubMed ID: 22515221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.